Trial Profile
improvement in renal function in high immunologic risk kidney transplant recipients switched from tacrolimus to belatacept
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Belatacept (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 22 Dec 2015 New trial record